80
Participants
Start Date
January 15, 2022
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2025
Ketamine
"Dual anti-glutamatergic therapy (DUAL) intervention group: patients who received ketamine as a continuous i.v. for 3 days (induction dose 1.5-3 mg/kg, followed by maintenance dose 2-10 mg/kg/h; dose adjustment according to EEG target of ketamine pattern) + oral perampanel via nasogastric tube for 5 days (12 mg if weight \> 60 kg; 9 mg if weight 50-60 kg; 6 mg if weight \< 50 kg), followed by gradual reduction according to clinical evolution."
Any anti-epileptic and anesthetic therapy, excluding Ketamine and Perampanel
Any antiseizure and anesthetic therapy according to usual clinical practice, excluding the two anti-glutamate drugs Ketamine and Perampanel
RECRUITING
Fondazione IRCCS San Gerardo dei Tintori Monza, Monza
RECRUITING
ASST Spedali Civili Brescia, Brescia
NOT_YET_RECRUITING
Ospedale Centrale di Bolzano, Bolzano
NOT_YET_RECRUITING
Ospedale G. Brotzu, Cagliari
NOT_YET_RECRUITING
Ospedale M. Bufalini, Cesena
NOT_YET_RECRUITING
AOU Careggi, Florence
NOT_YET_RECRUITING
Azienda Ospedaliero-Universitaria di Modena, Modena
NOT_YET_RECRUITING
Azienda Ospedaliero-Universitaria di Parma, Parma
RECRUITING
Ospedale Santa Chiara Trento, Trento
NOT_YET_RECRUITING
Azienda Ospedaliero-Universitaria Integrata di Verona, Verona
Azienda Ospedaliera San Gerardo di Monza
OTHER
Azienda Ospedaliero-Universitaria di Modena
OTHER
Azienda Ospedaliera Universitaria Integrata Verona
OTHER
Ospedale Centrale Bolzano
OTHER
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
OTHER
Azienda Ospedaliero-Universitaria Careggi
OTHER
Azienda Ospedaliero-Universitaria di Parma
OTHER
Santa Chiara Hospital
OTHER
Ospedale M. Bufalini Cesena
OTHER
Azienda Ospedaliera Brotzu
OTHER
Istituto Di Ricerche Farmacologiche Mario Negri
OTHER
University of Milano Bicocca
OTHER